Ann Plast Surg 2018 Apr;80(4 Suppl 4):S182-S188
From the Division of Plastic and Reconstructive Surgery, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
Download full-text PDF
Ann Plast Surg 2016 Jun;76(6):635-9
From the Department of Plastic Surgery, Georgetown University Hospital, Washington, DC.
Background: The impact of connective tissue disease (CTD) on outcomes following breast surgery and reconstruction is unknown. The purpose of this study was to evaluate the effect of both CTDs and systemic immunomodulatory therapy on outcomes following breast surgery and reconstruction.
Methods: A retrospective review was performed of all patients from 2005 to 2010 with an active CTD who underwent breast surgery with or without reconstruction. Read More
J Plast Reconstr Aesthet Surg 2013 Jan 5;66(1):61-6. Epub 2012 Aug 5.
Burns and Plastic Surgery, Canniesburn Unit, Glasgow Royal Infirmary, Glasgow G4 0SF, UK.
Introduction: The presence of severe underlying connective tissue disease may restrict the reconstructive options offered to a woman in the event of mastectomy. Putative concerns about reconstructive surgery include the effects of connective tissue disease and immunosuppression on wound healing and donor site morbidity, and increased risks of deranged clotting and thrombophilia after free tissue transfer. There is also the possibility of an unpredictable tissue reaction after oncological resection surgery and adjuvant radiotherapy. Read More
Ann Plast Surg 2013 Oct;71(4):335-41
From the *Division of Plastic and Reconstructive Surgery, Northwestern University, Feinberg School of Medicine, Chicago, IL; †Department of Plastic Surgery, University of Tennessee Health Science Center, Memphis, TN; and ‡Rosalind Franklin University of Medicine and Science, Chicago Medical School, North Chicago, IL.
Background: Recent health care legislation institutes penalties for surgical readmissions secondary to complications. There is a paucity of evidence describing risk factors for readmission after breast reconstruction procedures.
Methods: Patients undergoing breast reconstruction in 2011 were identified in the National Surgical Quality Improvement Program database. Read More
JAMA Surg 2017 Nov;152(11):1039-1047
Section of Plastic Surgery, University of Michigan Health System, Ann Arbor.
Importance: Cost variation among hospitals has been demonstrated for surgical procedures. Uncovering these differences has helped guide measures taken to reduce health care spending. To date, the fiscal consequence of hospital variation for autologous free flap breast reconstruction is unknown. Read More